Atlas Capital Advisors’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-40,000
| Closed | -$36.4K | – | 976 |
|
|
2023
Q4 | $36.4K | Hold |
40,000
| – | – | 0.01% | 629 |
|
|
2023
Q3 | $36.4K | Buy |
40,000
+15,000
| +60% | +$13.7K | 0.01% | 571 |
|
|
2023
Q2 | $96.3K | Hold |
25,000
| – | – | 0.01% | 479 |
|
|
2023
Q1 | $75.5K | Hold |
25,000
| – | – | 0.01% | 508 |
|
|
2022
Q4 | $51.3K | Hold |
25,000
| – | – | 0.01% | 537 |
|
|
2022
Q3 | $86.5K | Hold |
25,000
| – | – | 0.02% | 466 |
|
|
2022
Q2 | $105K | Sell |
25,000
-16,025
| -39% | -$67.5K | 0.02% | 453 |
|
|
2022
Q1 | $125K | Hold |
41,025
| – | – | 0.02% | 440 |
|
|
2021
Q4 | $191K | Hold |
41,025
| – | – | 0.03% | 364 |
|
|
2021
Q3 | $316K | Buy |
41,025
+23,227
| +131% | +$179K | 0.05% | 270 |
|
|
2021
Q2 | $153K | Buy |
+17,798
| New | +$153K | 0.03% | 394 |
|